News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
374,149 Results
Type
Article (22845)
Company Profile (29)
Press Release (351274)
Multimedia
Podcasts (115)
Webinars (13)
Section
Business (118337)
Career Advice (1413)
Deals (17199)
Drug Delivery (66)
Drug Development (41952)
Employer Resources (95)
FDA (8693)
Job Trends (8343)
News (188797)
Policy (16971)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1448)
Academic (1)
Accelerated approval (14)
Adcomms (14)
Allergies (89)
Alliances (33042)
ALS (108)
Alzheimer's disease (980)
Antibody-drug conjugate (ADC) (183)
Approvals (8935)
Artificial intelligence (342)
Autoimmune disease (99)
Automation (27)
Bankruptcy (157)
Best Places to Work (6959)
BIOSECURE Act (6)
Biosimilars (111)
Biotechnology (25)
Bladder cancer (112)
Brain cancer (33)
Breast cancer (413)
Cancer (3154)
Cardiovascular disease (266)
Career advice (1218)
Career pathing (29)
CAR-T (146)
CDC (23)
Cell therapy (458)
Cervical cancer (24)
Clinical research (36326)
Collaboration (1287)
Company closure (1)
Compensation (284)
Complete response letters (23)
COVID-19 (1484)
CRISPR (60)
C-suite (440)
Cystic fibrosis (80)
Data (4286)
Decentralized trials (2)
Denatured (40)
Depression (85)
Diabetes (339)
Diagnostics (3568)
Digital health (27)
Diversity (7)
Diversity, equity & inclusion (29)
Drug discovery (171)
Drug pricing (96)
Drug shortages (20)
Duchenne muscular dystrophy (149)
Earnings (57623)
Editorial (41)
Employer branding (12)
Employer resources (83)
Events (56962)
Executive appointments (529)
FDA (10714)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (6)
Frontotemporal dementia (17)
Funding (829)
Gene editing (125)
Generative AI (38)
Gene therapy (404)
GLP-1 (586)
Government (2342)
Grass and pollen (6)
Guidances (321)
Healthcare (10137)
HIV (45)
Huntington's disease (29)
IgA nephropathy (56)
Immunology and inflammation (148)
Immuno-oncology (37)
Indications (82)
Infectious disease (1625)
Inflammatory bowel disease (123)
Inflation Reduction Act (12)
Influenza (63)
Intellectual property (151)
Interviews (264)
IPO (8331)
IRA (30)
Job creations (1702)
Job search strategy (988)
JPM (43)
Kidney cancer (7)
Labor market (48)
Layoffs (250)
Leadership (28)
Legal (4366)
Liver cancer (45)
Longevity (9)
Lung cancer (434)
Lymphoma (266)
Machine learning (23)
Management (32)
Manufacturing (485)
MASH (118)
Medical device (6745)
Medtech (6776)
Mergers & acquisitions (9558)
Metabolic disorders (822)
Multiple sclerosis (112)
NASH (9)
Neurodegenerative disease (186)
Neuropsychiatric disorders (52)
Neuroscience (1731)
NextGen: Class of 2026 (3364)
Non-profit (2694)
Now hiring (8)
Obesity (357)
Opinion (194)
Ovarian cancer (91)
Pain (117)
Pancreatic cancer (139)
Parkinson's disease (168)
Partnered (21)
Patents (284)
Patient recruitment (244)
Peanut (29)
People (27787)
Pharmaceutical (8)
Pharmacy benefit managers (15)
Phase 1 (10887)
Phase 2 (15435)
Phase 3 (12966)
Pipeline (3867)
Policy (157)
Postmarket research (1631)
Preclinical (4772)
Press Release (31)
Prostate cancer (202)
Psychedelics (27)
Radiopharmaceuticals (165)
Rare diseases (534)
Real estate (2547)
Recruiting (37)
Regulatory (12846)
Reports (21)
Research institute (1358)
Resumes & cover letters (215)
Rett syndrome (19)
RNA editing (10)
RSV (42)
Schizophrenia (94)
Series A (146)
Series B (96)
Service/supplier (3)
Sickle cell disease (66)
Special edition (13)
Spinal muscular atrophy (75)
Sponsored (27)
Startups (1493)
State (1)
Stomach cancer (10)
Supply chain (54)
Tariffs (38)
The Weekly (74)
Vaccines (584)
Venture capital (46)
Weight loss (222)
Women's health (49)
Worklife (14)
Date
Today (80)
Last 7 days (360)
Last 30 days (1336)
Last 365 days (18843)
2026 (1930)
2025 (18935)
2024 (20124)
2023 (22132)
2022 (27903)
2021 (29690)
2020 (29016)
2019 (24969)
2018 (18449)
2017 (17382)
2016 (16925)
2015 (19283)
2014 (16176)
2013 (14155)
2012 (13978)
2011 (13392)
2010 (12623)
Location
Africa (542)
Alabama (58)
Alaska (4)
Arizona (128)
Arkansas (7)
Asia (21815)
Australia (3582)
California (6532)
Canada (1971)
China (664)
Colorado (309)
Connecticut (327)
Delaware (208)
Europe (51548)
Florida (1082)
Georgia (223)
Hawaii (1)
Idaho (23)
Illinois (491)
India (44)
Indiana (360)
Iowa (10)
Japan (291)
Kansas (73)
Kentucky (15)
Louisiana (8)
Maine (31)
Maryland (826)
Massachusetts (4808)
Michigan (197)
Minnesota (292)
Mississippi (1)
Missouri (58)
Montana (11)
Nebraska (9)
Nevada (89)
New Hampshire (34)
New Jersey (2108)
New Mexico (13)
New York (1871)
North Carolina (887)
North Dakota (5)
Northern California (3144)
Ohio (167)
Oklahoma (14)
Oregon (19)
Pennsylvania (1426)
Puerto Rico (7)
Rhode Island (25)
South America (748)
South Carolina (30)
Southern California (2648)
Tennessee (119)
Texas (1023)
United States (24026)
Utah (217)
Vermont (1)
Virginia (145)
Washington D.C. (52)
Washington State (540)
West Virginia (2)
Wisconsin (57)
Wyoming (2)
374,149 Results for "welsh carson anderson and stowe".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Integrated Biosciences Appoints Daniel J. Anderson, Ph.D. as Chief Scientific Officer
January 27, 2026
·
2 min read
Business
Adaeze Enekwechi Joins Welsh, Carson, Anderson & Stowe as an Operating Partner in the Firm’s Healthcare Group
Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that Dr. Adaeze Enekwechi will join the firm in June as an Operating Partner.
May 25, 2021
·
4 min read
Press Releases
IBA selected by MD Anderson Cancer Center to supply three Proteus®ONE systems
January 19, 2026
·
3 min read
Business
Welsh, Carson, Anderson & Stowe Commits $250 Million in a Strategic Partnership with Kiniciti, a Newly-Formed Platform Investing in Cell and Gene Therapy Companies
Welsh, Carson, Anderson & Stowe (“WCAS”), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that it is committing up to $250 million to a strategic partnership with Kiniciti, a newly-formed platform.
February 1, 2021
·
5 min read
Press Releases
TOLREMO therapeutics Welcomes Multiple Myeloma Leader Kenneth C. Anderson to its Scientific Advisory Board
October 30, 2025
·
4 min read
Business
Lee Cooper Joins Welsh, Carson, Anderson & Stowe As An Operating Partner in the Firm’s Healthcare Group
Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that Lee Cooper, an accomplished healthcare executive, has joined the firm as an Operating Partner.
October 7, 2019
·
2 min read
Business
Dan Mendelson Joins Welsh, Carson, Anderson & Stowe As An Operating Partner in the Firm’s Healthcare Group
Welsh, Carson, Anderson & Stowe announced today that Dan Mendelson, a highly-regarded executive in the healthcare industry, has joined the firm’s Healthcare team as an Operating Partner.
April 8, 2019
·
2 min read
Business
Dr. Paul Taheri Joins Welsh, Carson, Anderson & Stowe As An Operating Partner in the Firm’s Healthcare Group
Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that Paul Taheri, MD, MBA and currently CEO of Yale Medicine and a Deputy Dean for Clinical Affairs at the Yale School of Medicine, has joined the firm’s healthcare team as an Operating Partner.
September 10, 2019
·
2 min read
Press Releases
CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia
October 2, 2025
·
4 min read
Earnings
Bayer Earnings ‘Not Pretty,’ CEO Bill Anderson Admits As He Urges Calm
Bayer reported a decline of 37% in earnings per share on Tuesday, which sent its stock down 12%. CEO Bill Anderson urged investors to be patient as the company executes on a performance-boosting strategy outlined in March.
November 12, 2024
·
2 min read
·
Annalee Armstrong
1 of 37,415
Next
